IP Verse

Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist

Patent No. EP2228064 (titled "Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist") was filed by Novartis on May 17, 2005. The application was issued on Dec 11, 2019.

Patent Summary

A medicament for treating inflammatory or obstructive airways diseases comprises glycopyrrolate (A) and a compound of formula I (B), administered separately, together, simultaneously, sequentially, or separately. Compound (B) is in free, salt, or solvate form, where the substituent W is defined by specific parameters: $R^1=OH$; $R^2, R^3, R^4, R^7, R^8, R^9, R^{10}=H$; $R^x, R^y=-CH_2-$; and $R^5, R^6=CH_3CH_2-$. The medicament may include co-therapeutic agents (e.g., steroids, PDE4 inhibitors) and be formulated as a pharmaceutical composition, such as a dry powder in capsules, a multi-dose dry powder inhaler, or an aerosol for metered-dose inhalation. It is applicable to asthma (including "wheezy-infant syndrome"), COPD, cystic fibrosis, and pneumoconiosis. The invention further provides pharmaceutical kits and inhalation devices for delivering these components.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR. SCHNEIDER KUNSTSTOFFWERKE GMBHSep 11, 2020SCHON
DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBBSep 11, 2020SCHON
EUROPEAN OPPOSITIONSSep 11, 2020KILBURN & STRODE
HGFSep 11, 2020HARRISON GODDARD FOOTE
ISARPATENTSep 11, 2020ISARPATENT
NEDERLANDSCH OCTROOIBUREAUSep 11, 2020NEDERLANDSCH OCTROOIBUREAU
STADA ARZNEIMITTELSep 11, 2020HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
ORION ORION PHARMASep 11, 2020J A KEMP
PGASep 10, 2020PGA
HOFFMANN EITLESep 8, 2020HOFFMANN EITLE
TEVA UK LIMITEDSep 8, 2020ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2228064

NOVARTIS
Application Number
EP10164976A
Filing Date
May 17, 2005
Status
Granted And Under Opposition
Nov 8, 2019
Publication Date
Dec 11, 2019
External Links
Slate, Register , Google Patents